Literature DB >> 9341113

Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.

B Ren1, A P Thelen, J M Peters, F J Gonzalez, D B Jump.   

Abstract

Dietary polyunsaturated fatty acids (PUFA) induce hepatic peroxisomal and microsomal fatty acid oxidation and suppress lipogenic gene expression. The peroxisome proliferator-activated receptor alpha (PPARalpha) has been implicated as a mediator of fatty acid effects on gene transcription. This report uses the PPARalpha-deficient mouse to examine the role of PPARalpha in the PUFA regulation of mRNAs encoding hepatic lipogenic (fatty acid synthase (FAS) and the S14 protein (S14)), microsomal (cytochrome P450 4A2 (CYP4A2)), and peroxisomal (acyl-CoA oxidase (AOX)) enzymes. PUFA ingestion induced mRNAAOX (2.3-fold) and mRNACYP4A2 (8-fold) and suppressed mRNAFAS and mRNAS14 by >/=80% in wild type mice. In PPARalpha-deficient mice, PUFA did not induce mRNAAOX or mRNACYP4A2, indicating a requirement for PPARalpha in the PUFA-mediated induction of these enzymes. However, PUFA still suppressed mRNAFAS and mRNAS14 in the PPARalpha-deficient mice. Studies in rats provided additional support for the differential regulation of lipogenic and peroxisomal enzymes by PUFA. These studies provide evidence for two distinct pathways for PUFA control of hepatic lipid metabolism. One requires PPARalpha and is involved in regulating peroxisomal and microsomal enzymes. The other pathway does not require PPARalpha and is involved in the PUFA-mediated suppression of lipogenic gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341113     DOI: 10.1074/jbc.272.43.26827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage.

Authors:  Arantza Ibabe; Eider Bilbao; Miren P Cajaraville
Journal:  Histochem Cell Biol       Date:  2004-12-23       Impact factor: 4.304

Review 2.  Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.

Authors:  Kembra Albracht-Schulte; Nishan Sudheera Kalupahana; Latha Ramalingam; Shu Wang; Shaikh Mizanoor Rahman; Jacalyn Robert-McComb; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2018-02-27       Impact factor: 6.048

Review 3.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

4.  Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice.

Authors:  Hervé Guillou; Pascal Martin; Sophie Jan; Sabine D'Andrea; Alain Roulet; Daniel Catheline; Vincent Rioux; Thierry Pineau; Philippe Legrand
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

5.  Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System.

Authors:  Ruiyin Chu; Weihua Zhang; Hanjo Lim; Anjana V Yeldandi; Chris Herring; Laura Brumfield; Janardan K Reddy; Matthew Davison
Journal:  Gene Expr       Date:  2002

Review 6.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

Review 7.  Fatty acid-regulated transcription factors in the liver.

Authors:  Donald B Jump; Sasmita Tripathy; Christopher M Depner
Journal:  Annu Rev Nutr       Date:  2013-03-22       Impact factor: 11.848

8.  Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice.

Authors:  Ping Zhang; Elena Boudyguina; Martha D Wilson; Abraham K Gebre; John S Parks
Journal:  J Nutr Biochem       Date:  2007-12-21       Impact factor: 6.048

Review 9.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

Review 10.  Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.